BioHealth News Archive
Serpin Pharma Receives FDA Approval for COVID-19 Clinical Investigation
Manassas, VA - On June 17, 2020, Serpin Pharma was notified by the U.S. Food and Drug Administration (FDA) that it may proceed with…
Read More
AstraZeneca chief helps Deloitte launch Life Sciences Catalyst in Cambridge | Business Weekly | Technology News | Business news | Cambridge and the East of England
Deloitte has launched the Life Sciences Catalyst in Cambridge, a collaborative platform enabling organisations in the biotech, medtech, pharmaceutical and technology sectors, as well…
Read More
Cerecor Announces First Patient Enrolled in Multicenter Proof-of-Concept Study Evaluating CERC-002 for COVID-19 ARDS Nasdaq:CERC
ROCKVILLE, Md., July 21, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and…
Read More
What Safe Shopping Looks Like During the Pandemic
To limit the spread of Covid-19, the U.S. Centers for Disease Control and Prevention recommends that individuals practice social distancing. When local conditions allow…
Read More
JHTV Contracts Team Finds Extra Meaning in Supporting Researchers’ COVID-19 Work | Johns Hopkins Technology Ventures
Virologist Andrew Pekosz has a team of 15 people working around the clock in his lab at the Johns Hopkins Bloomberg School of Public…
Read More
BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., Virtually Sits Down with Rich Bendis for BioTalk
BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., joins BioTalk to discuss his background with the University of Maryland, the BioHealth Capital Region,…
Read More
KidneyX Summit Announces Winners of the Redesign Dialysis Phase 2 Prize | Kidney News
Today, July 22nd, a virtual summit was hosted by KidneyX to announce the six winners of the Redesign Dialysis Phase 2 prize. The goal…
Read More
Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment
BALTIMORE, July 23, 2020 /PRNewswire/ -- Vita Therapeutics, Inc. announced today that it received orphan drug designation (ODD) from the U.S. Food and Drug Administration…
Read More
D.C. imposes self-quarantine for travelers from 27 states – Washington Business Journal
D.C. is requiring people making travel into Washington from 27 states to self-quarantine because of new surges in Covid-19 cases. The order went into…
Read More
Leading through Change and Resilency Classes Available Through MC
Montgomery College announces several pop-up, remote classes which could be valuable for you and your teams: : Sustaining Resilience MGT632 (crn#16869), August 5, 2020, …
Read More
Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction
NEW YORK – Liquid biopsy firm Creatv MicroTech is developing a diagnostic platform that measures the amount and size of specific circulating stromal cells called…
Read More
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19 Vaccine Candidate
Researchers from AstraZeneca, the University of Oxford, and its spinout company Vaccitech today published preliminary Phase I/II data showing their closely-watched COVID-19 vaccine candidate…
Read More
5 Questions with Sara Nayeem, M.D., a Partner at New Enterprise Associates (NEA) · BioBuzz
“5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
citybizlist : Washington DC : “COVID-19-Edition” of Pediatric Medical Device Competition Announces Finalists
Sixteen finalists are announced in the "Make Your Medical Device Pitch for Kids!” special COVID-19 edition competition presented by the National Capital Consortium for…
Read More
Eight Drivers that Will Define Digital Health in the 2020s | by Robert Lord | LionBird | Jul, 2020 | Medium
As we embark on our third fund at LionBird, we believe that proactively thinking deeply about what will drive the next decade of healthcare…
Read More